MapLight Therapeutics
The Director, Pharmacovigilance (PV) Operations leads the strategy, planning, and execution of safety databases and outsourced PV activities for MapLight Therapeutics. This role oversees the collection, evaluation, and reporting of safety data from clinical trials while shaping the company’s safety governance framework. The position supports strategic decisions related to PV operations across programs and ensures regulatory compliance.
MapLight Therapeutics is a biotechnology company focused on redefining the standard of care for brain disorders through targeted CNS treatments. The company leverages a proprietary discovery platform combining optogenetics, STARmap, and transcriptomics to identify and target individual neural circuits that misfire in brain disorders. Its clinical pipeline includes compounds for schizophrenia, Alzheimer's disease psychosis, and autism spectrum disorder, while its preclinical pipeline addresses Parkinson's disease, hyperactivity, and impulsivity.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for MapLight Therapeutics.
Associate Director, Pharmacovigilance (PV)
PTC Therapeutics
Safety & PV Specialist II
Syneos Health
Director, Drug Safety & Pharmacovigilance Scientist
Dyne Therapeutics
Senior Director, Patient Safety & Pharmacovigilance
Latigobio
Associate Director, Pharmacovigilance Scientist
Tango Therapeutics
PV Scientist
Replimune